Ledger.Open graph →
SEC Form D · Amendment · filed March 24, 2016

Aptimmune Biologics, Inc

Offering
$3.3M
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CHAMPAIGN, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Federico Zuckermann · Champaign, ILExec · DirectorRobert Easter · Champaign, ILDirectorPaul Olivo · Champaign, ILDirectorGary Durack · Champaign, ILDirectorAaron Gilbertie · Champaign, ILExec · DirectorJohn Wadsworth · Lindon, UTExec · DirectorPhilip M. Halpern · White Plains, NYDirectorTalei Capital LLC · Lindon, UTExec · DirectorBrant Frank · Lindon, UTDirectorGregory R. Piefer · Monona, WIDirectorDonald M. Whelley · Wilton, CTExec · DirectorJeffrey Hadden · Gretna, NEDirectorVenky Ganesan · Menlo Park, CAExec · DirectorTingfu Qiao · Houston, TXDirectorStephen A. Dominy · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗